Multiprofile Hospital for Active Treatment Dr. Ivan Seliminski - Sliven AD

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Chronic kidney disease
• Coronary artery disease
• Peripheral artery disease

Running trials

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

  Contact: Trial Registration Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Peripheral artery disease1 recruiting